Global Sale Purchase Of Stock vs Change To Account Receivables Analysis
GLH Stock | 0.13 0.01 7.14% |
Global Health financial indicator trend analysis is much more than just examining Global Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Global Health is a good investment. Please check the relationship between Global Health Sale Purchase Of Stock and its Change To Account Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Sale Purchase Of Stock vs Change To Account Receivables
Sale Purchase Of Stock vs Change To Account Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Global Health Sale Purchase Of Stock account and Change To Account Receivables. At this time, the significance of the direction appears to have very week relationship.
The correlation between Global Health's Sale Purchase Of Stock and Change To Account Receivables is 0.25. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Change To Account Receivables in the same time period over historical financial statements of Global Health, assuming nothing else is changed. The correlation between historical values of Global Health's Sale Purchase Of Stock and Change To Account Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Global Health are associated (or correlated) with its Change To Account Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Account Receivables has no effect on the direction of Sale Purchase Of Stock i.e., Global Health's Sale Purchase Of Stock and Change To Account Receivables go up and down completely randomly.
Correlation Coefficient | 0.25 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Sale Purchase Of Stock
Change To Account Receivables
Most indicators from Global Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Global Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Tax Provision is likely to gain to about 335.3 K in 2024, whereas Selling General Administrative is likely to drop slightly above 784.2 K in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 8.5M | 11.5M | 9.9M | 7.2M | Interest Expense | 27.7K | 17.8K | 76.3K | 61.6K |
Global Health fundamental ratios Correlations
Click cells to compare fundamentals
Global Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Global Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 39.0M | 42.4M | 56.0M | 57.5M | 58.0M | 61.0M | |
Total Assets | 6.6M | 9.0M | 11.0M | 3.1M | 3.1M | 5.3M | |
Short Long Term Debt Total | 816.4K | 304.1K | 141.8K | 44.9K | 1.0M | 1.1M | |
Other Current Liab | 1.0M | 1.5M | 1.2M | 1.5M | 1.6M | 1.2M | |
Total Current Liabilities | 4.9M | 4.7M | 4.8M | 4.7M | 5.1M | 3.6M | |
Total Stockholder Equity | 1.2M | 4.0M | 6.1M | (1.6M) | (2.9M) | (2.8M) | |
Property Plant And Equipment Net | 236.8K | 8.6K | 9.7K | 8.8K | 20.5K | 19.4K | |
Current Deferred Revenue | 2.6M | 2.4M | 2.9M | 2.5M | 3.0M | 1.7M | |
Net Debt | 150.1K | (4.5M) | (6.2M) | (2.2M) | (1.0M) | (1.1M) | |
Accounts Payable | 673.9K | 619.1K | 579.4K | 625.4K | 334.9K | 476.3K | |
Cash | 666.3K | 4.8M | 6.4M | 2.2M | 2.1M | 1.5M | |
Non Current Assets Total | 4.6M | 3.5M | 3.9M | 8.9K | 20.5K | 19.4K | |
Non Currrent Assets Other | (448.2K) | 116.4K | 150.4K | (8.9K) | (1.0) | (1.05) | |
Cash And Short Term Investments | 666.3K | 4.8M | 6.4M | 2.2M | 2.1M | 1.5M | |
Net Receivables | 1.2M | 550.5K | 492.7K | 703.7K | 819.6K | 893.5K | |
Liabilities And Stockholders Equity | 6.6M | 9.0M | 11.0M | 3.1M | 3.1M | 5.3M | |
Non Current Liabilities Total | 615.0K | 339.9K | 125.0K | 46.6K | 862.6K | 493.3K | |
Total Liab | 5.5M | 5.0M | 4.9M | 4.7M | 6.0M | 4.3M | |
Property Plant And Equipment Gross | 236.8K | 211.5K | 213.4K | 213.3K | 192.0K | 182.4K | |
Total Current Assets | 2.0M | 5.5M | 7.2M | 3.1M | 3.1M | 2.6M | |
Accumulated Other Comprehensive Income | 292.1K | 1.1M | 2.1M | 2.0M | 81.4K | 77.3K | |
Short Term Debt | 541.8K | 162.3K | 141.8K | (3.3M) | 179.3K | 188.2K | |
Common Stock | 21.7M | 24.4M | 27.3M | 27.7M | 27.7M | 20.9M | |
Retained Earnings | (20.9M) | (21.4M) | (23.3M) | (31.3M) | (30.7M) | (29.1M) | |
Other Current Assets | 114.0K | 140.5K | 251.5K | 163.0K | 170.4K | 222.4K | |
Intangible Assets | 4.1M | 4.1M | 3.9M | 3.0M | 3.5M | 0.0 | |
Other Liab | 1.4M | 198.1K | 184.5K | 46.6K | 53.6K | 50.9K | |
Other Assets | 508.1K | 540.9K | 414.4K | 0.0 | 1.0 | 0.95 | |
Property Plant Equipment | 236.8K | 8.6K | 9.7K | 8.8K | 7.9K | 7.5K | |
Net Tangible Assets | (3.7M) | 1.1M | 2.6M | (1.6M) | (1.9M) | (2.0M) | |
Short Long Term Debt | 360.1K | 159.5K | 141.1K | 44.9K | 40.4K | 38.4K | |
Long Term Investments | 116.4K | 118.4K | 240.0 | 109.0 | 125.35 | 119.08 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Global Stock Analysis
When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.